Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EV/Core EBITDA

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 32.66153.69244.10

What is the latest EV/Core EBITDA ratio of GENPHARMASEC ?

The latest EV/Core EBITDA ratio of GENPHARMASEC is 32.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202532.66
Mar2024153.69
Mar2023244.10

How is EV/Core EBITDA of GENPHARMASEC Trending?

Years EV/Core EBITDA % Change
Mar2025 32.66
-78.75
Mar2024 153.69
-37.04
Mar2023 244.1 -

Other Financial Ratios of GENPHARMASEC


Compare EV/Core EBITDA ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹64.2 Cr NA -12.1% -51.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,226.8 Cr 3% -5.2% -6% Stock Analytics
KIRI INDUSTRIES ₹3,001.7 Cr 9% -12.1% -22.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,581.5 Cr 2.2% -4.1% -35.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,096.4 Cr -3.1% -5.3% 27.7% Stock Analytics
BODAL CHEMICALS ₹646.3 Cr 8.5% -2% -17.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-12.1%

-51.9%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses